The value of friends in a battle: Terry Kalley and the Genentech Avastin battle with the FDA

Posted by Michael Wong on April 19, 2011 · 1 Comment 

On December 16, 2010, the FDA issued a press release regarding the Genentech drug Avastin. The headline to the release says it all: FDA begins process to remove breast cancer indication from Avastin label: Drug not shown to be safe and effective in breast cancer patients On Genentech’s side are Washington lawyers, lobbyists and a national … Continue reading →

Category Better Thinking, Insurers, KOLs, Payers, Pharmaceutical · Tagged with , , ,

Is it alright to pay people to blog about a product?

Posted by Michael Wong on February 28, 2011 · 9 Comments 

Abbott recently put out an app for the iPhone regarding its infant formula Similac. The app “can easily track baby’s eating, sleeping … diaper changes … [and] predict the next feeding time”. Now the controversy of formula substituting for breast milk is an old one. My dad, who was with UNICEF, was one of the … Continue reading →

Category Better Thinking, KOLs, Pharmaceutical, Physician Detailing, Sales · Tagged with , , , , ,